These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 9420304)

  • 1. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.
    Saha K; Bentsman G; Chess L; Volsky DJ
    J Virol; 1998 Jan; 72(1):876-81. PubMed ID: 9420304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines.
    Kinter AL; Ostrowski M; Goletti D; Oliva A; Weissman D; Gantt K; Hardy E; Jackson R; Ehler L; Fauci AS
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14076-81. PubMed ID: 8943063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.
    Jansson M; Popovic M; Karlsson A; Cocchi F; Rossi P; Albert J; Wigzell H
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15382-7. PubMed ID: 8986820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.
    Pierdominici M; Giovannetti A; Ensoli F; Mazzetta F; Marziali M; De Cristofaro MR; Santini-Muratori D; Leti W; Aiuti F
    J Acquir Immune Defic Syndr; 2002 Feb; 29(2):122-31. PubMed ID: 11832680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.
    Jennes W; Sawadogo S; Koblavi-Dème S; Vuylsteke B; Maurice C; Roels TH; Chorba T; Nkengasong JN; Kestens L
    AIDS Res Hum Retroviruses; 2002 Feb; 18(3):171-7. PubMed ID: 11839151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do beta-chemokines have clinical relevance in HIV infection?
    Mackewicz CE; Barker E; Greco G; Reyes-Teran G; Levy JA
    J Clin Invest; 1997 Aug; 100(4):921-30. PubMed ID: 9259592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.
    Giovannetti A; Ensoli F; Mazzetta F; De Cristofaro M; Pierdominici M; Muratori DS; Fiorelli V; Aiuti F
    Clin Exp Immunol; 1999 Oct; 118(1):87-94. PubMed ID: 10540164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpesvirus saimiri transformation of HIV type 1 suppressive CD8+ lymphocytes from an HIV type 1-infected asymptomatic individual.
    Lacey SF; Weinhold KJ; Chen CH; McDanal C; Oei C; Greenberg ML
    AIDS Res Hum Retroviruses; 1998 Apr; 14(6):521-31. PubMed ID: 9566555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals.
    Lewis MJ; Gautier VW; Wang XP; Kaplan MH; Hall WW
    J Immunol; 2000 Oct; 165(7):4127-32. PubMed ID: 11034425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status.
    Garzino-Demo A; Moss RB; Margolick JB; Cleghorn F; Sill A; Blattner WA; Cocchi F; Carlo DJ; DeVico AL; Gallo RC
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11986-91. PubMed ID: 10518563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of circulating beta-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals.
    Kakkanaiah VN; Ojo-Amaize EA; Peter JB
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):499-502. PubMed ID: 9665956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation.
    Greco G; Fujimura SH; Mourich DV; Levy JA
    J Virol; 1999 Feb; 73(2):1528-34. PubMed ID: 9882358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.
    De Luca A; Giancola ML; Cingolani A; Ammassari A; Murri R; Antinori A
    AIDS Res Hum Retroviruses; 2000 Jun; 16(9):835-43. PubMed ID: 10875609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha.
    Casoli C; Vicenzi E; Cimarelli A; Magnani G; Ciancianaini P; Cattaneo E; Dall'Aglio P; Poli G; Bertazzoni U
    Blood; 2000 May; 95(9):2760-9. PubMed ID: 10779418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.
    Annunziato F; Galli G; Nappi F; Cosmi L; Manetti R; Maggi E; Ensoli B; Romagnani S
    Blood; 2000 Feb; 95(4):1167-74. PubMed ID: 10666186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
    Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-MIP-1alpha and anti-RANTES antibodies: new allies of HIV-1?
    Kissler S; Süsal C; Opelz G
    Clin Immunol Immunopathol; 1997 Sep; 84(3):338-41. PubMed ID: 9281393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages.
    Moriuchi H; Moriuchi M; Combadiere C; Murphy PM; Fauci AS
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15341-5. PubMed ID: 8986813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.